Skip to main content
. 2022 Jan 11;119(1):68–76. doi: 10.1159/000520452

Table 1.

Baseline and MgSO4-related clinical characteristics of the study population

Period 1 (n = 79) Period 2 (n = 72) Period 3 (n = 75) p value
Baseline characteristics
Gestational age, weeks (min, max) 24.0±0.9 (22+1, 25+6) 24.2±0.1 (22+5, 25+6) 23.9±0.9 (22+1, 25+6) 0.201
Birth weight, g (min, max) 667±145 (320, 940) 683±134 (300, 950) 667±129 (380, 940) 0.719
Male, n (%) 45 (57) 39 (54) 39 (52) 0825
Small for gestational age, n (%) 13 (16) 11 (15) 13 (17) 0.945
Apgar score at 1 min 4.3±1.6 4.4±1.4 4.3±1.7 0.957
Apgar score at 5 min 6.8±1.9 6.9±1.3 7.0±1.6 0.546
Cesarean delivery, n (%) 57 (72) 55 (76) 39 (52) 0.003
Antenatal steroid use, n (%) 76 (94) 66 (92) 73 (97) 0.325
Preterm premature rupture of membranes, n (%) 30 (38) 22 (31) 37 (49) 0.063
Histologic chorioamnionitis, n (%) 50 (63) 40 (56) 57 (87) 0.031
Preeclampsia, n (%) 5 (6) 6 (8) 4 (5) 0.759
Gestational diabetes, n (%) 2 (3) 1 (1) 1 (1) 0.816

Antenatal MgSO4 use, n (%)
For any purpose 19 (24) 56 (78) 16 (21)
For neuroprotection 1 (3) 40 (56) 0 (0) <0.001
For severe preeclampsia 5 (6) 6 (8) 4 (5)
For tocolysis 13 (16) 10 (14) 12 (16)

Serum MgSO4 level of EPIs
Initial level (<1 h), mg/dL 2.6±1.3 2.8±0.9 2.3±0.6 0.021
Peak level within the first week, mg/dL 2.8±1.0 3.0±0.7 2.7±0.5 <0.001
Initial ionized calcium level, mmol/L 1.26±0.17 1.28±0.14 1.25±0.15 0.408
Total intake on day 1, mL/kg/day 70±7 73±6 71±10 0.888
Total intake on day 7, mL/kg/day 110±12 109±18 113±13 0.932

Type of milk during the first month or until alive, n (%)
Exclusive breastfeeding 34 (43) 37 (51) 40 (53)
Partial breastfeeding 31 (39) 23 (32) 31 (41) 0.231
Formula milk 8 (10) 6 (8) 2 (3)
Nil per os 6 (8) 6 (8) 2 (3)

MgSO4, magnesium sulfate; EPI, extremely premature infant.